{"id":"https://openalex.org/W43739593","doi":null,"title":"Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.","display_name":"Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.","alternate_titles":[],"publication_year":1998,"publication_date":"1998-05-01","ids":{"openalex":"https://openalex.org/W43739593","mag":"43739593","pmid":"https://pubmed.ncbi.nlm.nih.gov/9832941"},"language":"en","primary_location":{"id":"pmid:9832941","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9832941","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W43739593"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078088256","display_name":"Elise M. Weerts","orcid":"https://orcid.org/0000-0002-8234-0919","observed_orcids":["https://orcid.org/0000-0002-8234-0919"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E M Weerts","raw_affiliation_strings":["Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. eweerts@welchlink.welch.jhu.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. eweerts@welchlink.welch.jhu.edu","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112911888","display_name":"R R Griffiths","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R R Griffiths","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7866,"has_fulltext":false,"cited_by_count":33,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.65166062,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"9","issue":"3","first_page":"285","last_page":"297"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.10350000113248825,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zolpidem","display_name":"zolpidem","score":0.9929999709129333},{"id":"https://openalex.org/keywords/self-injection","display_name":"self-injection","score":0.9340000152587891},{"id":"https://openalex.org/keywords/physical-dependence","display_name":"physical dependence","score":0.875},{"id":"https://openalex.org/keywords/benzodiazepine-dependence","display_name":"benzodiazepine dependence","score":0.7979999780654907},{"id":"https://openalex.org/keywords/flumazenil","display_name":"flumazenil","score":0.6919999718666077},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal-syndrome","display_name":"benzodiazepine withdrawal syndrome","score":0.9020000100135803},{"id":"https://openalex.org/keywords/midazolam","display_name":"midazolam","score":0.8859999775886536},{"id":"https://openalex.org/keywords/fixed-ratio-schedules","display_name":"fixed-ratio schedules","score":0.7260000109672546},{"id":"https://openalex.org/keywords/continuous-availability","display_name":"continuous availability","score":0.5070000290870667},{"id":"https://openalex.org/keywords/baboons","display_name":"baboons","score":0.5540000200271606},{"id":"https://openalex.org/keywords/drug-self-administration","display_name":"self-administration","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C2777123777","wikidata":"https://www.wikidata.org/wiki/Q218842","display_name":"Zolpidem","level":3,"score":0.9797918796539307},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.799443244934082},{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.7693907022476196},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6134430170059204},{"id":"https://openalex.org/C2778195246","wikidata":"https://www.wikidata.org/wiki/Q2622112","display_name":"Physical dependence","level":3,"score":0.5980318188667297},{"id":"https://openalex.org/C2779594886","wikidata":"https://www.wikidata.org/wiki/Q159429","display_name":"Baboon","level":2,"score":0.5644088983535767},{"id":"https://openalex.org/C2778000748","wikidata":"https://www.wikidata.org/wiki/Q423071","display_name":"Midazolam","level":3,"score":0.5609567165374756},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.5432913899421692},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.43908417224884033},{"id":"https://openalex.org/C2778555786","wikidata":"https://www.wikidata.org/wiki/Q7448011","display_name":"Self-administration","level":2,"score":0.42642027139663696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42179742455482483},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.4144956171512604},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3220635652542114},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.22382092475891113},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19185322523117065},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07323554158210754},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.0},{"id":"https://openalex.org/C2781210498","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Insomnia","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077334","descriptor_name":"Zolpidem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005442","descriptor_name":"Flumazenil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005502","descriptor_name":"Food","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010215","descriptor_name":"Papio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012646","descriptor_name":"Self Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D018757","descriptor_name":"GABA Modulators","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9832941","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9832941","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"},{"id":"mag:43739593","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9832941","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6695298939","display_name":"ABUSE LIABILITY OF BENZODIAZEPINES AND CAFFEINE","funder_award_id":"R01DA001147","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2290279581","https://openalex.org/W2017578873","https://openalex.org/W2263080779","https://openalex.org/W2315502678","https://openalex.org/W2027098651","https://openalex.org/W2075743352","https://openalex.org/W2081515670","https://openalex.org/W2019275032","https://openalex.org/W2263877944","https://openalex.org/W1995829545"],"abstract_inverted_index":{"Intravenous":[0],"zolpidem":[1,62,127,147,171,200,220,250,256],"self-injection,":[2],"and":[3,46,61,108,135,182,204,230,240,259],"the":[4,49,57,140,245],"concurrent":[5],"development":[6,50],"of":[7,12,34,51,74,90,106,111,126,144,170,189,199,208,216,265],"physical":[8,52,260],"dependence":[9,53,261],"under":[10,22,69,263],"conditions":[11,264],"continuous":[13,267],"drug":[14],"availability,":[15],"was":[16,251],"characterized":[17],"in":[18,48,54,132,139,152,164,175,185],"three":[19,166],"baboons.":[20,55,167],"Previously,":[21],"similar":[23,233],"conditions,":[24],"1.0":[25],"mg/kg":[26],"midazolam":[27],"maintained":[28,86,100,177,257],"low,":[29],"but":[30],"stable,":[31],"daily":[32,109],"rates":[33,110,125],"self-injection":[35,68,112,128,169,201,221,258],"(e.g.":[36],"less":[37,93,158],"than":[38,94,115,159],"20":[39],"injections/day)":[40],"over":[41,137],"30":[42],"or":[43,119],"more":[44,120],"days":[45,198,248],"resulted":[47],"In":[56],"current":[58],"experiments,":[59],"saline":[60,116,145,217],"(1.0":[63],"mg/kg)":[64],"were":[65,113,129,232,241],"available":[66],"for":[67,146],"a":[70,78,149,209,223],"fixed-ratio":[71],"(FR-30)":[72],"schedule":[73],"lever-pull":[75],"responses":[76],"with":[77],"5":[79],"min":[80],"time-out":[81],"after":[82,194,218,249],"each":[83],"injection.":[84],"Saline":[85],"only":[87],"low":[88,156],"levels":[89],"responding":[91,153,176],"(i.e.":[92,117,157],"five":[95,160],"injections":[96,107,121,161],"per":[97,122,162],"day).":[98,123],"Zolpidem":[99],"an":[101,173,183],"orderly":[102],"spaced":[103],"within-day":[104],"pattern":[105],"higher":[114],"10":[118],"Daily":[124],"relatively":[130],"stable":[131],"two":[133],"baboons,":[134],"increased":[136],"time":[138],"third":[141],"baboon.":[142],"Substitution":[143,215],"produced":[148,172,202,222],"rapid":[150],"decrease":[151],"that":[154],"remained":[155],"day)":[163],"all":[165],"Chronic":[168],"increase":[174,184],"by":[178],"food":[179],"pellet":[180],"delivery":[181],"body":[186],"weights.":[187],"Administration":[188],"flumazenil":[190],"(0.1-1.0":[191],"mg/kg,":[192],"i.v.)":[193],"at":[195],"least":[196],"35":[197],"postures":[203,231],"behavioral":[205],"signs":[206,229],"typical":[207],"classic":[210],"flumazenil-precipitated":[211,238],"benzodiazepine":[212],"withdrawal":[213,226,239],"syndrome.":[214,227],"chronic":[219],"time-limited":[224],"spontaneous":[225],"Behavioral":[228],"to":[234],"those":[235],"observed":[236],"during":[237,244],"most":[242],"prominent":[243],"first":[246],"8":[247],"discontinued.":[252],"Therefore,":[253],"like":[254],"midazolam,":[255],"developed":[262],"long-term":[266],"availability.":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W43739593","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
